Third Rock Ventures II, L.P.

Insider Reports History

Entity
Company
Location
29 Newbury Street, 3 Rd Floor, Boston, MA
Signature
/s/ Kevin Gillis, Chief Operating Officer of TRV GP II, LLC, general partner of Third Rock Ventures GP II, L.P., general partner of Third Rock Ventures II, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Third Rock Ventures II, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 3.05M $5.64M $1.85 Sep 15, 2021 Indirect
Jounce Therapeutics, Inc. 10%+ Owner Common Stock 2.7M $4.99M $1.85 Sep 15, 2021 Direct
Revolution Medicines, Inc. 10%+ Owner Common Stock 12.9K $349K $27.00 Jun 3, 2021 Indirect
Revolution Medicines, Inc. 10%+ Owner Common Stock 0 $27.00 Jun 4, 2021 Direct

Insider Reports Filed by Third Rock Ventures II, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
JNCE Jounce Therapeutics, Inc. Sep 15, 2021 1 $0 4 Sep 17, 2021 10%+ Owner
JNCE Jounce Therapeutics, Inc. Jun 10, 2021 1 $0 4 Jun 14, 2021 10%+ Owner
RVMD Revolution Medicines, Inc. Jun 3, 2021 2 -$16.4M 4 Jun 7, 2021 10%+ Owner
RVMD Revolution Medicines, Inc. May 25, 2021 2 -$41.8M 4 May 27, 2021 10%+ Owner
JNCE Jounce Therapeutics, Inc. May 25, 2021 1 -$4.42M 4 May 27, 2021 10%+ Owner